A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7812653 in Participants With Early Symptomatic Alzheimer's Disease (eAD)
Clinical trial NCT07234942 · RECRUITING
Trial details
- NCT number
- NCT07234942
- Sponsor
- Hoffmann-La Roche
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-27
- Primary completion
- 2029-12-03
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.